We also evaluated the in vivo anti-cancer effects following ablation of the HIF-1α signaling pathway using a doxycycline-inducible Notch1 RNA-interfering system or by treating cells with chetomin and validated the correlation between HIF-1α and Notch1 expression using clinical tissues from GBM patients. Here, NOTCH1 is linked to cancer.